rs12721454
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BA1
The NM_002069.6(GNAI1):c.645C>T(p.Phe215=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0109 in 1,612,860 control chromosomes in the GnomAD database, including 1,729 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.059 ( 912 hom., cov: 32)
Exomes 𝑓: 0.0059 ( 817 hom. )
Consequence
GNAI1
NM_002069.6 synonymous
NM_002069.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.378
Genes affected
GNAI1 (HGNC:4384): (G protein subunit alpha i1) Guanine nucleotide binding proteins are heterotrimeric signal-transducing molecules consisting of alpha, beta, and gamma subunits. The alpha subunit binds guanine nucleotide, can hydrolyze GTP, and can interact with other proteins. The protein encoded by this gene represents the alpha subunit of an inhibitory complex. The encoded protein is part of a complex that responds to beta-adrenergic signals by inhibiting adenylate cyclase. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 7-80211023-C-T is Benign according to our data. Variant chr7-80211023-C-T is described in ClinVar as [Benign]. Clinvar id is 3056616.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.378 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.201 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNAI1 | NM_002069.6 | c.645C>T | p.Phe215= | synonymous_variant | 6/8 | ENST00000649796.2 | NP_002060.4 | |
GNAI1 | NM_001256414.2 | c.489C>T | p.Phe163= | synonymous_variant | 6/8 | NP_001243343.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNAI1 | ENST00000649796.2 | c.645C>T | p.Phe215= | synonymous_variant | 6/8 | NM_002069.6 | ENSP00000497260 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0585 AC: 8901AN: 152064Hom.: 909 Cov.: 32
GnomAD3 genomes
AF:
AC:
8901
AN:
152064
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0154 AC: 3882AN: 251294Hom.: 395 AF XY: 0.0119 AC XY: 1616AN XY: 135814
GnomAD3 exomes
AF:
AC:
3882
AN:
251294
Hom.:
AF XY:
AC XY:
1616
AN XY:
135814
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00593 AC: 8662AN: 1460678Hom.: 817 Cov.: 29 AF XY: 0.00513 AC XY: 3729AN XY: 726756
GnomAD4 exome
AF:
AC:
8662
AN:
1460678
Hom.:
Cov.:
29
AF XY:
AC XY:
3729
AN XY:
726756
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0586 AC: 8915AN: 152182Hom.: 912 Cov.: 32 AF XY: 0.0570 AC XY: 4243AN XY: 74408
GnomAD4 genome
AF:
AC:
8915
AN:
152182
Hom.:
Cov.:
32
AF XY:
AC XY:
4243
AN XY:
74408
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
34
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
GNAI1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 23, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at